From 2023-2025, a large Division I university implemented Sharpen® DTX, a digital care coordination and therapeutics platform combining universal mental health and suicide risk screening (CAT-MH®) with peer-focused mental health literacy and athlete wellness modules. Over 3 years 1,275 student-athletes completed the program. 9.9% were flagged for elevated suicide risk and received same-day clinical triage via Sharpen dashboard. Download full white paper.

The landscape of pediatric behavioral health continues to face significant challenges, with wait times for psychiatric care extending upwards of nine months in many health systems. At Resiliency Technologies, we're addressing this critical gap through evidence-based digital therapeutics that integrate seamlessly into clinical workflows. Here's what we've been building...

Sharpen DTX has been awarded a grant from the South Carolina Research Authority (SCRA) to develop and validate our go-to-market strategy with healthcare payors and providers.

Resiliency Technologies celebrates an important partnership with EMRAY, an integration platform for health innovators that enables seamless embedding into healthcare provider workflows through electronic health record (EHR) pre-integration. 

Resiliency Technologies is proud to announce our ongoing collaboration with the UC Berkeley Data Discovery program to create our proprietary Sharpen DTX AI recommendation engine.  We have been working with the program since 2021 and this collaboration represents a significant milestone in our mission to transform mental health care through innovative digital therapeutics.

Sharpen DTX is now live on Charm Health Hub and is interoperable with electronic health records - making important strides in collaborative care.